The short-term impacts of the decriminalization of illegal drug possession on clients dispensed opioid agonist treatment medications and visits to supervised consumption services and overdose prevention services in British Columbia, Canada (2015–2023)
Authors:
- Sami Aftab AbdulSASami Aftab Abdul
- Huan JiangHJHuan Jiang
- Cayley RussellCRCayley Russell
- Tara Elton-MarshallTETara Elton-Marshall
- Farihah AliFAFarihah Ali
- Iesha HendersonIHIesha Henderson
- Bernard Le FollBernard Le Foll
- Brooke KinniburghBKBrooke Kinniburgh
- Jürgen RehmJRJürgen Rehm
- Sameer ImtiazSISameer Imtiaz
- 21 October 2025
- journal article
- Published by Elsevier in Journal of Substance Use and Addiction Treatment
- Vol. 180, 209815
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
- Institute of Neurosciences Mental Health and Addiction
This publication has 26 references indexed in Scilit:
- Decriminalization or police mission creep? Critical appraisal of law enforcement involvement in British Columbia, Canada's decriminalization frameworkInternational Journal of Drug Policy, 2024
- Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic reviewInternational Journal of Drug Policy, 2024
- Benzodiazepine Withdrawal in the Context of Benzodiazepine-Contaminated Opioids: Practice ImplicationsThe Journal for Nurse Practitioners, 2023
- One-Year Association of Drug Possession Law Change With Fatal Drug Overdose in Oregon and WashingtonJAMA Psychiatry, 2023
- Changes in arrests following decriminalization of low-level drug possession in Oregon and WashingtonInternational Journal of Drug Policy, 2023
- Does drug decriminalization increase unintentional drug overdose deaths?Journal of Health Economics, 2023
- The continuous opioid death crisis in Canada: changing characteristics and implications for path options forwardThe Lancet Regional Health - Americas, 2023
- The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutionsInternational Journal of Drug Policy, 2022
- Trajectories of retention in opioid agonist therapy in a Canadian settingInternational Journal of Drug Policy, 2020
- An analysis of variance test for normality (complete samples)Biometrika, 1965